EIF5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 9.9111829854337E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.44870000019193E-07 |
Normal-vs-Stage2 |
1.98087999999652E-05 |
Normal-vs-Stage3 |
5.50670620214078E-14 |
Normal-vs-Stage4 |
3.7873038039038E-12 |
Stage1-vs-Stage2 |
1.116000E-01 |
Stage1-vs-Stage3 |
1.76039999999489E-06 |
Stage1-vs-Stage4 |
2.16239999999424E-05 |
Stage2-vs-Stage3 |
1.038440E-01 |
Stage2-vs-Stage4 |
1.038630E-01 |
Stage3-vs-Stage4 |
8.220400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.82691664416279E-12 |
Normal-vs-AfricanAmerican |
3.96150000000484E-05 |
Normal-vs-Asian |
7.524200E-02 |
Caucasian-vs-AfricanAmerican |
5.617000E-01 |
Caucasian-vs-Asian |
4.517400E-01 |
AfricanAmerican-vs-Asian |
6.251000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.73061565078569E-12 |
Normal-vs-Female |
5.00840000028369E-07 |
Male-vs-Female |
1.070120E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.91210000002984E-07 |
Normal-vs-Age(41-60Yrs) |
6.16800055475153E-10 |
Normal-vs-Age(61-80Yrs) |
5.44979616989849E-11 |
Normal-vs-Age(81-100Yrs) |
4.604400E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.985560E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.700000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.450200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.280800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.929400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.455800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.935600E-01 |
Normal-vs-Grade 2 |
1.62327999999601E-05 |
Normal-vs-Grade 3 |
2.55295784512555E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
2.517200E-01 |
Grade 1-vs-Grade 3 |
5.940600E-03 |
Grade 1-vs-Grade 4 |
3.97149999999957E-05 |
Grade 2-vs-Grade 3 |
1.77977999999968E-05 |
Grade 2-vs-Grade 4 |
1.51140000514971E-09 |
Grade 3-vs-Grade 4 |
1.196230E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
9.84419999999764E-05 |
Normal-vs-ccB subtype |
6.80566714095221E-14 |
ccA subtype-vs-ccB subtype |
1.68499999997351E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.99980065629779E-11 |
Normal-vs-N1 |
2.05240000550333E-08 |
N0-vs-N1 |
3.871700E-02 |
|
|